indication cannot be made with the available data. Randomized controlled trials are certainly needed to determine the association between statins and decreased mortality risk from esophageal cancer. TAVANKIT 
LETTERS TO THE EDITOR

Flu vaccine and gout attacks
To the Editor: In the December 2019 issue, Dr. Sherif Mossad reported how to respond to 12 reasons people give for not wanting to receive the inactivated infl uenza vaccine. 1 His article provides much help to clinicians. I wish to add a question to support Dr. Mossad's article: Does the risk of gout attack increase after receiving a inactivated infl uenza vaccine? A case-crossover study reported that people who received a nonzoster vaccine had a 2-fold increased odds of developing a gout attack within 2 days of vaccination (adjusted odds ratio 1.99, 95% confi dence interval 1.01-3.89). 2 The authors commented that the benefi ts of vaccinations on individual persons and on public health are enormous, so rejecting vaccination out of fear of an increased risk of gout attacks is not advisable, as the benefi t outweighs the risk. 2 A preliminary analysis using the database of the Taiwan National Health Insurance Program reported that among people age 65 and older, the incidence rate of a gout attack within 30 days after vaccination was similar between the vaccination group and the nonvaccination group (0.05 vs 0.05 per 1,000 person-days, 95% confi dence interval 0.73-1.57; P = .735). 3 The authors commented that at least older people were not at increased risk of a gout attack after infl uenza vaccination.
At present, no other systematic research has been conducted on the association between infl uenza vaccine and gout attack. Other real-world data are needed to clarify this issue.
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